Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (REPL)

Group 1 - A securities class action lawsuit has been filed against Replimune Group, Inc. for alleged violations of federal securities laws during the class period from November 22, 2024, to October 21, 2025 [1][2] - The complaint claims that the defendants made false and misleading statements regarding the IGNYTE trial, which was deemed inadequate by the FDA due to known material issues [2] - Investors are encouraged to contact the firm before the lead plaintiff motion deadline on September 22, 2025, to discuss their rights and interests in the class action [3]